HIMS | Hims & Hers HealthNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$25.70
+$0.46 (+1.82%)

Hims & Hers Health (HIMS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $25.70 vs 50 $28.76 / 200 $26.97
Projection
Death cross estimated in 14 to 20 bars
Test
No active test
Last cross
Golden cross 30 Jul 2026 ยท projected 28 bars out ยท tested 6 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $27.68 vs 50 $28.29 / 200 $24.19
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
below both $25.70 vs 50 $28.71 / 200 $30.43
Projection
No cross projected
Test
No active test
Last cross
Death cross 11 Sep 2026 bar 1 ยท projected 9 bars out ยท tested 2 bars

Cross history

16
crosses on record since 2022
8 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
11 Sep 2026Death4-hour9 bars out2 bar cross test
30 Jul 2026Golden flatdaily28 bars out6 bar cross test
8 May 2026Golden4-hour23 bars out3 bar cross test
8 Dec 2025Death steepdaily30 bars outNot tested
5 Nov 2025Death4-hour27 bars outNot tested

About HIMS

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$273M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.